FDA Estimates GSK Seizure Involves $4 Bil. Worth Of Product
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's seizure of GlaxoSmithKline's Paxil CR and Avandamet is the agency's largest in terms of monetary value, involving $4 bil. worth of product, the agency said